Abilitech Medical Obtains Health Canada License

SCI Accelerate member to enter the Canadian marketplace with assistive technology to improve quality of life for people with spinal cord injury.

“We’re excited to build connections and demonstrate outcomes with clinicians and patients throughout Canada. Our device is intuitive and easy to use, can be leveraged in numerous settings and benefits families as well as patients by lessening the burden of care.” — Angie Conley, founder and CEO of Abilitech Medical

Abilitech writing support

Praxis Spinal Cord Institute has exciting news on a member of the Praxis Commercialization Program.

Abilitech Medical, part of the SCI Accelerate 2021 cohort, has just been issued a Medical Device Establishment License (MDEL) from Health Canada. This commercial license will provide individuals in Canada with access to Abilitech’s medical device, the Abilitech Assist™, which makes everyday activities possible for people with spinal cord injury that have arm limitations. The license also allows Abilitech to work with Canadian medical device partners.

Praxis is proud to have Abilitech in our alumni group of accelerator companies. We look forward to seeing their impact on improved quality of life for people with spinal cord injury.


For more information, visit Abilitech Medical:


Praxis is supported by